Sonny Hsiao

Biography

Dr. Hsiao is the principle investigator of two NIH grants to evaluate Adheren’s cell therapy technology. His PhD research at UC Berkeley resulted in an patent for a novel cell therapy based on bio-conjugation. Dr. Hsiao has extensive research experience in the field of T cell and NK cell therapy and has contributed both to the discovery of components of the Antibody-Cell Conjugation (ACC™) technology to the invention of new T cell immunotherapy.  

Research Interest

 immunology